Robitussin Tos Seca
- Manufacturer
- Haleon US Holdings LLC
- Effective date
- 2024-04-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- full-release
- Hydrated at
- 2026-06-01 00:11:28
Label at a glance#
ProductRobitussin Tos Seca
Active ingredientDEXTROMETHORPHAN HYDROBROMIDE
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0031-8652-79 | Robitussin Tos Seca | 118 mL in 1 BOTTLE | SYRUP | 118 | 6 | |
| 0031-8652-79 | Robitussin Tos Seca | 1 in 1 CARTON | SYRUP | 1 | 6 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Robitussin Tos Seca
- dextromethorphan hydrobromide
- DEXTROSE, UNSPECIFIED FORM
- GLYCERIN
- METHYLPARABEN
- HONEY
- PROPYLENE GLYCOL
- SODIUM BENZOATE
- WATER
- DEXTROMETHORPHAN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0031-8652 | 0031-8652-79 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DEXTROSE, UNSPECIFIED FORM | IY9XDZ35W2 | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| HONEY | Y9H1V576FH | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| WATER | 059QF0KO0R | IACT |
| DEXTROMETHORPHAN HYDROBROMIDE | 9D2RTI9KYH | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 16d9f80d-61f0-4406-e063-6294a90ac099 | ee22055b-6bb3-45b6-a789-14d5b81c2d8b | 2024-04-24 | 16d9f80d-61f0-4406-e063-6294a90ac099 ee22055b-6bb3-45b6-a789-14d5b81c2d8b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
